Correlation Between Incyte and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Incyte and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incyte and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incyte and Spero Therapeutics, you can compare the effects of market volatilities on Incyte and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incyte with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incyte and Spero Therapeutics.
Diversification Opportunities for Incyte and Spero Therapeutics
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Incyte and Spero is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Incyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incyte are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Incyte i.e., Incyte and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Incyte and Spero Therapeutics
Given the investment horizon of 90 days Incyte is expected to under-perform the Spero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Incyte is 1.98 times less risky than Spero Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Spero Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 153.00 in Spero Therapeutics on February 20, 2024 and sell it today you would earn a total of 6.00 from holding Spero Therapeutics or generate 3.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Incyte vs. Spero Therapeutics
Performance |
Timeline |
Incyte |
Spero Therapeutics |
Incyte and Spero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Incyte and Spero Therapeutics
The main advantage of trading using opposite Incyte and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incyte position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.Incyte vs. Sino Biopharmaceutical Ltd | Incyte vs. Eledon Pharmaceuticals | Incyte vs. Rezolute | Incyte vs. XOMA Corporation |
Spero Therapeutics vs. International Growth Fund | Spero Therapeutics vs. MIRA Pharmaceuticals Common | Spero Therapeutics vs. Fidelity Water Sustainability | Spero Therapeutics vs. Merck Company |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |